BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8453506)

  • 1. Increased bone growth by local prostaglandin E2 in rats.
    Yang RS; Liu TK; Lin-Shiau SY
    Calcif Tissue Int; 1993 Jan; 52(1):57-61. PubMed ID: 8453506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H; Ke HZ; Jee WS; Sakou T
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2.
    Jee WS; Ueno K; Kimmel DB; Woodbury DM; Price P; Woodbury LA
    Bone; 1987; 8(3):171-8. PubMed ID: 3475073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
    Bone; 1994; 15(5):489-96. PubMed ID: 7980959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass.
    Ueno K; Haba T; Woodbury D; Price P; Anderson R; Jee WS
    Bone; 1985; 6(2):79-86. PubMed ID: 3860213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones.
    Weinreb M; Rutledge SJ; Rodan GA
    Bone; 1997 Apr; 20(4):347-53. PubMed ID: 9108355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
    Jee WS; Lin BY; Ma YF; Ke HZ
    J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 16,16-dimethyl prostaglandin E2 methyl ester on weanling rat skeleton: daily and systemic administration.
    Furuta Y; Jee WS
    Anat Rec; 1986 Jul; 215(3):305-16. PubMed ID: 3740468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats.
    Ke HZ; Jee WS
    Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraosseous infusion of prostaglandin E2 in the caprine tibia.
    Welch RD; Johnston CE; Waldron MJ; Poteet B
    J Orthop Res; 1993 Jan; 11(1):110-21. PubMed ID: 8423513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.
    Mori S; Jee WS; Li XJ
    Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats.
    Lin CH; Jee WS; Ma YF; Setterberg RB
    Bone; 1995 Oct; 17(4 Suppl):255S-259S. PubMed ID: 8579925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.
    Desimone DP; Greene VS; Hannon KS; Turner RT; Bell NH
    J Bone Miner Res; 1993 May; 8(5):625-34. PubMed ID: 8511990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
    Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
    Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation.
    Jee WS; Ueno K; Deng YP; Woodbury DM
    Calcif Tissue Int; 1985 Mar; 37(2):148-57. PubMed ID: 3924371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats.
    Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS
    Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats.
    Jee WS; Ke HZ; Li XJ
    Bone Miner; 1991 Oct; 15(1):33-55. PubMed ID: 1747567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intramedullary infusion of prostaglandin E2 stimulates bone formation both in the bone marrow and in the periosteum.
    Takada M; Yamamoto I; Yuu I; Kigami Y; Ohnaka Y; Morita R
    Endocr J; 1995 Jun; 42(3):323-30. PubMed ID: 7670560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.